| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,936 | 34,058 | 31,987 | 47,170 | | Cost of Revenue | 4,126 | 9,944 |
-
| 1,619 | | | Gross Profit | 23,810 | 24,114 | 31,987 | 45,551 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,357 | 4,138 | 6,528 | 2,996 | | Non Recurring | (123,298) | 123,710 |
-
| 4,827 | | Others | (540) | (76,254) | 76,820 | 124,325 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (94,247) | (27,480) | (51,361) | (86,596) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (42,547) | 12,736 | 82,255 |
-
| | Earnings Before Interest And Taxes | (162,155) | (45,971) | 33,402 | (86,942) | | Interest Expense | 20,797 | 21,091 | 19,151 | 21,297 | | Income Before Tax | (182,953) | (67,062) | 14,251 | (108,239) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (59) | (18,562) |
-
| (167) | | | | Net Income From Continuing Ops | (20,239) | (67,062) | 14,251 | (108,239) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (44,135) | (67,062) | 14,251 | (108,239) | | Preferred Stock And Other Adjustments |
-
| 18,505 | (18,505) |
-
| | | Net Income Applicable To Common Shares | ($44,135) | ($48,557) | ($4,254) | ($108,239) |
|
0.02% Nasdaq 
0.33%
Income Statement
